trial · primary record
Psilocybin
Borderline Personality Disorder
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2025-12-01 |
| Primary endpoint | Change in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score |
| Registry ID | NCT05399498 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:28.881Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05399498
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Psilocybin · compound